boromycin : A boron-containing macrolide antibiotic that is isolated from Streptomyces antibioticus.
ID Source | ID |
---|---|
PubMed CID | 86289396 |
CHEBI ID | 77880 |
SCHEMBL ID | 788223 |
MeSH ID | M0040397 |
Synonym |
---|
34524-20-4 |
eth 28829 |
boromycin |
[(2r)-1-{(1r)-1-[(1r,2r,5s,6r,8r,12r,14s,17r,18r,19r,22s,24z,28s,30s,33r)-12,28-dihydroxy-1,2,18,19-tetra(hydroxy-kappao)-6,13,13,17,29,29,33-heptamethyl-3,20-dioxo-4,7,21,34,35-pentaoxatetracyclo[28.3.1.1(5,8).1(14,18)]hexatriacont-24-en-22-yl]ethoxy}-3- |
CHEBI:77880 |
SCHEMBL788223 |
Role | Description |
---|---|
antibacterial agent | A substance (or active part thereof) that kills or slows the growth of bacteria. |
anti-HIV agent | An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
zwitterion | A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer). |
organoboron compound | A compound containing at least one carbon-boron bond. |
macrolide antibiotic | A macrocyclic lactone with a ring of twelve or more members which exhibits antibiotic activity. |
oxaspiro compound | A spiro compound in which at least one of the cyclic components is an oxygen heterocyle. |
macrodiolide | A macropolylide which contains two ester linkages in one macrocyclic ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |